Ophthalmology Devices Market Size, Share, Growth Analysis, By Product(Surgical & Vision Care), By Application(Cataract and Glaucoma), By End-user(Hospitals, Ophthalmic Clinics, Eye Clinics and Others), By Region - Industry Forecast 2025-2032

There has been a significant increase in the prevalence of ophthalmic disorders, including cataract, diabetic retinopathy, myopia, age-related macular degeneration, etc. The increasing prevalence of ophthalmic disorders, along with the increasing initiatives undertaken by national and regional agencies to promote eye health are responsible for higher diagnosis rates in developed and emerging countries. According to Centers for Disease Control and Prevention (CDC) the number of diabetic retinopathy cases in America is expected to rise from 7.7 million in 2010 to 14.6 million in 2050. 

Eye infections are a major cause of severe eye pain. Eye pain is accompanied by symptoms such as dry eyes, burning and pain. This can be caused by many factors including foreign irritants, infection or trauma. Eyelashes or dirt particles, smoke, dust or some harsh makeup products are the most common causes of irritated, red and watery eyes. With increasing pharmaceutical industry and pollution worldwide, the prevalence of eye pain continues to show an increase. Chemical burns and flash burns cause severe eye pain and severity due to irritation of the cornea. Style and blepharitis are common causes of eye pain as they increase the sensitivity of the eye and oil glands surrounding the area. 

Various factors including lower per capita healthcare expenditure, limited product accessibility, and lack of awareness about ophthalmic diseases, lead to a lower number of patients undergoing treatment in emerging nations. For instance, according to the article published in 2018 in The Ophthalmologist: Clinical and Therapeutic Journal, the cataract surgery rate in China was 2,450 per million inhabitants which were lower in comparison to cataract surgery rate in the U.S. that was around 11, 920 per million inhabitants. 

The COVID-19 outbreak has had a negative impact on the ophthalmology devices market. The significant decline in the number of ophthalmic procedures due to the COVID pandemic has led to a decline of revenues generated by market players from the sales of implants, consumable, and equipment. The surgical segment is projected to witness a higher decline in revenues including cataract surgeries, vitreoretinal surgeries, and other procedures, which has been responsible for lower sales of Implants, equipment, and consumables. According to the analysis of an estimated 228 hospitals in the U.S. (which accounts for over 2 million patient visits annually), showed that there was a massive decline of around 81% patient visits for ophthalmology during March and April 2020, as compared to 2019.